Search research articles
Contact Us
Filters
Showing results (81-90 of 167) with videos related to
Page
of 17
Sort By:
International Journal of Neonatal Screening
|
November 5, 2020
Instability of Acylcarnitines in Stored Dried Blood Spots: The Impact on Retrospective Analysis of Biomarkers for Inborn Errors of Metabolism
Willemijn J van Rijt, Peter C J I Schielen, Yasemin Özer, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
|
December 25, 2017
Molybdenum cofactor deficiency type A: Prenatal monitoring using MRI
Charlotte M A Lubout, Terry G J Derks, Linda Meiners, et al.
The Journal of Pediatrics
|
June 2, 2006
The natural history of medium-chain acyl CoA dehydrogenase deficiency in the Netherlands: clinical presentation and outcome
Terry G J Derks, Dirk-Jan Reijngoud, Hans R Waterham, et al.
Molecular Genetics and Metabolism
|
October 16, 2025
Urinary tetraglucoside excretion as a biomarker in liver glycogen storage diseases
Ruben J Overduin, Candelas Gross-Valle, Joost Groen, et al.
Journal of Lipid Research
|
September 21, 2024
A specific serum lipid signature characterizes patients with glycogen storage disease type Ia
Alessandro Rossi, Margherita Ruoppolo, Roberta Fedele, et al.
Human Molecular Genetics
|
December 10, 2019
Glycogen storage disease type 1a is associated with disturbed vitamin A metabolism and elevated serum retinol levels
Ali Saeed, Joanne A Hoogerland, Hanna Wessel, et al.
Italian Journal of Pediatrics
|
July 3, 2021
Crohn disease-like enterocolitis remission after empagliflozin treatment in a child with glycogen storage disease type Ib: a case report
Alessandro Rossi, Erasmo Miele, Simona Fecarotta, et al.
JIMD Reports
|
January 26, 2017
What Is the Best Blood Sampling Time for Metabolic Control of Phenylalanine and Tyrosine Concentrations in Tyrosinemia Type 1 Patients?
Esther van Dam, Anne Daly, Gineke Venema-Liefaard, et al.
Pediatrics
|
September 24, 2014
Favorable outcome after physiologic dose of sodium-D,L-3-hydroxybutyrate in severe MADD
Willemijn J Van Rijt, M Rebecca Heiner-Fokkema, Gideon J du Marchie Sarvaas, et al.
Journal of Inherited Metabolic Disease
|
May 27, 2024
Repurposing SGLT2 inhibitors: Treatment of renal proximal tubulopathy in Fanconi-Bickel syndrome with empagliflozin
Ruben J Overduin, Sarah C Grünert, Martine T P Besouw, et al.
Page
of 17
Search research articles
Search
Showing results (81-90 of 167) with videos related to
Sort By:
Page
of 17
International Journal of Neonatal Screening
|
November 5, 2020
Instability of Acylcarnitines in Stored Dried Blood Spots: The Impact on Retrospective Analysis of Biomarkers for Inborn Errors of Metabolism
Willemijn J van Rijt, Peter C J I Schielen, Yasemin Özer, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
|
December 25, 2017
Molybdenum cofactor deficiency type A: Prenatal monitoring using MRI
Charlotte M A Lubout, Terry G J Derks, Linda Meiners, et al.
The Journal of Pediatrics
|
June 2, 2006
The natural history of medium-chain acyl CoA dehydrogenase deficiency in the Netherlands: clinical presentation and outcome
Terry G J Derks, Dirk-Jan Reijngoud, Hans R Waterham, et al.
Molecular Genetics and Metabolism
|
October 16, 2025
Urinary tetraglucoside excretion as a biomarker in liver glycogen storage diseases
Ruben J Overduin, Candelas Gross-Valle, Joost Groen, et al.
Journal of Lipid Research
|
September 21, 2024
A specific serum lipid signature characterizes patients with glycogen storage disease type Ia
Alessandro Rossi, Margherita Ruoppolo, Roberta Fedele, et al.
Human Molecular Genetics
|
December 10, 2019
Glycogen storage disease type 1a is associated with disturbed vitamin A metabolism and elevated serum retinol levels
Ali Saeed, Joanne A Hoogerland, Hanna Wessel, et al.
Italian Journal of Pediatrics
|
July 3, 2021
Crohn disease-like enterocolitis remission after empagliflozin treatment in a child with glycogen storage disease type Ib: a case report
Alessandro Rossi, Erasmo Miele, Simona Fecarotta, et al.
JIMD Reports
|
January 26, 2017
What Is the Best Blood Sampling Time for Metabolic Control of Phenylalanine and Tyrosine Concentrations in Tyrosinemia Type 1 Patients?
Esther van Dam, Anne Daly, Gineke Venema-Liefaard, et al.
Pediatrics
|
September 24, 2014
Favorable outcome after physiologic dose of sodium-D,L-3-hydroxybutyrate in severe MADD
Willemijn J Van Rijt, M Rebecca Heiner-Fokkema, Gideon J du Marchie Sarvaas, et al.
Journal of Inherited Metabolic Disease
|
May 27, 2024
Repurposing SGLT2 inhibitors: Treatment of renal proximal tubulopathy in Fanconi-Bickel syndrome with empagliflozin
Ruben J Overduin, Sarah C Grünert, Martine T P Besouw, et al.
Page
of 17